Jamunarani Veeraraghavan

FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

Xiaoyong Fu, Resel Pereira, Carmine De Angelis et al. · Proceedings of the National Academy of Sciences · 2019 · 171 citations · Full text

Medicine, Genetics, Oncology +17

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

Aleix Prat, Tomás Pascual, Carmine De Angelis et al. · JNCI Journal of the National Cancer Institute · 2019 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17

Recurrent ESR1–CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers

Jamunarani Veeraraghavan, Ying Tan, Xi-Xi Cao et al. · Nature Communications · 2014 · 152 citations · Full text

Medicine, Genetics, Oncology +14

HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer

Xiaowei Xu, Carmine De Angelis, Kathleen A. Burke et al. · Clinical Cancer Research · 2017 · 129 citations · Full text

Medicine, Genetics, Oncology +15

Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo et al. · Clinical Cancer Research · 2021 · 94 citations · Full text

Medicine, Oncology, Pharmacology +17